| 摘要 |
A method for treatment or prevention of prostate cancer by administering an effective amount of a compound of the formula (I) or a pharmaceutically acceptable salt or ester thereof. In formula (I) (which follows) , each of R1 and R2 is a hydrogen atom, a hydroxyl group, a protected hydroxyl group or a lower alkoxy group.
|
